Home  /  Resource Library  /  Mosunetuzumab Monotherapy Is an Effective and Well Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received >2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study

Mosunetuzumab Monotherapy Is an Effective and Well Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received >2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study

ASH 2021